Loukas Kakoullis 🦠🌴🦟
@loukasmd.bsky.social
Chief Resident at Mount Auburn Hospital
Clinical Fellow at Harvard Medical School
Soon to be ID Fellow at MGH/BWH
Aspiring Epidemiologist & Antimicrobial Steward
Tropical Medicine enthusiast
Clinical Fellow at Harvard Medical School
Soon to be ID Fellow at MGH/BWH
Aspiring Epidemiologist & Antimicrobial Steward
Tropical Medicine enthusiast
Reposted by Loukas Kakoullis 🦠🌴🦟
New from @loukasmd.bsky.social et al:
Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units
▶️ 39 studies, various sources including water, construction, contamination
#IDSky
📄: doi.org/10.1017/ice....
Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units
▶️ 39 studies, various sources including water, construction, contamination
#IDSky
📄: doi.org/10.1017/ice....
April 22, 2025 at 2:04 PM
New from @loukasmd.bsky.social et al:
Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units
▶️ 39 studies, various sources including water, construction, contamination
#IDSky
📄: doi.org/10.1017/ice....
Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units
▶️ 39 studies, various sources including water, construction, contamination
#IDSky
📄: doi.org/10.1017/ice....
Reposted by Loukas Kakoullis 🦠🌴🦟
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort Study
Babesiosis poses significant risks of adverse outcomes in individuals with immunocompromising conditions (IC) and asplenia/hyposplenia (AH). This study compares clinical outcomes between these vulnerable groups and immunocompetent patients.
buff.ly
January 31, 2025 at 12:12 AM
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Babesiosis in immunocompetent Vs immunocompromised & asplenic patients:
🔹 Higher rates of parasitemia & complications
🔹 Higher recurrence rates with hematologic malignancies and B-cell depletion
🔹 Blood smears & PCR didn’t reliably predict relapse
#IDSky #Babesiosis #InfectiousDiseases
🔹 Higher rates of parasitemia & complications
🔹 Higher recurrence rates with hematologic malignancies and B-cell depletion
🔹 Blood smears & PCR didn’t reliably predict relapse
#IDSky #Babesiosis #InfectiousDiseases
Comparative Outcomes of Babesiosis in Immunocompromised and Non-Immunocompromised Hosts: A Multicenter Cohort Study
This retrospective cohort of 113 immunocompetent and 112 immunocompromised and/or asplenic/hyposplenic patients found higher complication, mortality, and r
academic.oup.com
February 2, 2025 at 3:59 AM
Babesiosis in immunocompetent Vs immunocompromised & asplenic patients:
🔹 Higher rates of parasitemia & complications
🔹 Higher recurrence rates with hematologic malignancies and B-cell depletion
🔹 Blood smears & PCR didn’t reliably predict relapse
#IDSky #Babesiosis #InfectiousDiseases
🔹 Higher rates of parasitemia & complications
🔹 Higher recurrence rates with hematologic malignancies and B-cell depletion
🔹 Blood smears & PCR didn’t reliably predict relapse
#IDSky #Babesiosis #InfectiousDiseases
Reposted by Loukas Kakoullis 🦠🌴🦟
ONE ANTIBIOTIC PK TABLE TO RULE THEM ALL
Absorption takes drug into blood from GI,
Vd spreads drug out to where bug calls home.
And after bacteria are doomed to die,
The drug’s eliminated on the porcelain throne
In the Land of Notion where this table doth lie…
#idSky #microsky #pharmsky #medsky
Absorption takes drug into blood from GI,
Vd spreads drug out to where bug calls home.
And after bacteria are doomed to die,
The drug’s eliminated on the porcelain throne
In the Land of Notion where this table doth lie…
#idSky #microsky #pharmsky #medsky
January 26, 2025 at 7:48 PM
Joining this crew is a dream come true! 🎉🌽
Can't wait to meet you all and begin my career in ID!
Can't wait to meet you all and begin my career in ID!
🤩 WE ARE SUPER EXCITED to announce our 2025-2027 class of ID Fellows! 🥂
We are thrilled to have matched with such a talented group!
We are thrilled to have matched with such a talented group!
December 7, 2024 at 11:53 PM
Joining this crew is a dream come true! 🎉🌽
Can't wait to meet you all and begin my career in ID!
Can't wait to meet you all and begin my career in ID!